Comera Life Sciences Holdings, Inc. Common Stock
CMRA
CMRA was delisted on the 16th of November, 2023.
14 hedge funds and large institutions have $194K invested in Comera Life Sciences Holdings, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and closing their positions.
88% more capital invested
Capital invested by funds: $103K → $194K (+$90.9K)
27% more funds holding
Funds holding: 11 → 14 (+3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Corient Private Wealth
Miami,
Florida
|
+$260K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.21K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.38K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.36K |
| 5 |
JP Morgan Chase
New York
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$7.99K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$6 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Corient Private Wealth
Miami,
Florida
| $123K | +$260K | +493,692 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $22.4K | +$5.38K | +10,204 | +17% |
|
3
HighTower Advisors
Chicago,
Illinois
| $14K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $12.9K | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $9.44K | – | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $5.57K | +$9.21K | +17,458 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $2.33K | +$3.36K | +6,366 | +386% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2.14K | -$13 | -24 | -0.3% |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $1.05K | -$7.99K | -15,150 | -81% |
|
10
Morgan Stanley
New York
| $668 | – | – | – |
|
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| $190 | – | – | – |
|
|
12
Wells Fargo
San Francisco,
California
| $25 | -$6 | -11 | -11% |
|
|
13
JP Morgan Chase
New York
| $4 | +$7 | +13 | New |
|
CMRA Hedge Fund Activity: Q3 2023 in Review
14 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Common Stock (CMRA) for Q3 2023, worth a combined $194K — up 88% from $103K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CMRA positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Corient Private Wealth, opening a new position worth an estimated $260K. The largest seller was Osaic Holdings, cutting an estimated $7.99K.
- 14 institutional investors held Comera Life Sciences Holdings, Inc. Common Stock (CMRA) as of Q3 2023, up from 11 in Q2 2023.
- Funds reported $194K of Comera Life Sciences Holdings, Inc. Common Stock stock for Q3 2023, up 88% quarter-over-quarter.
- 3 funds opened new Comera Life Sciences Holdings, Inc. Common Stock positions in Q3 2023 and 0 closed out, a net change of +3 holders.
- The largest Comera Life Sciences Holdings, Inc. Common Stock buyer in Q3 2023 was Corient Private Wealth, an estimated $260K added.
- The largest Comera Life Sciences Holdings, Inc. Common Stock seller in Q3 2023 was Osaic Holdings, an estimated $7.99K sold.
Based on aggregated 13F filings for Q3 2023.